Nomura Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Nomura Holdings’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.55M	Sell	2,000 -3,000	-60%	-$2.3M	﹤0.01%	1009
2025 Q4	$3.86M	Hold	5,000	–	–	0.01%	873
2025 Q3	$2.81M	Hold	5,000	–	–	﹤0.01%	1006
2025 Q2	$2.63M	Hold	5,000	–	–	0.01%	763
2025 Q1	$3.17M	Sell	5,000 -19,400	-80%	-$13.3M	0.01%	871
2024 Q4	$17.4M	Buy	24,400 +5,000	+26%	+$4.2M	0.02%	369
2024 Q3	$20.4M	Hold	19,400	–	–	0.05%	265
2024 Q2	$20.4M	Sell	19,400 -4,500	-19%	-$4.36M	0.04%	256
2024 Q1	$23M	Buy	23,900 +9,900	+71%	+$9.41M	0.06%	234
2023 Q4	$12.3M	Buy	14,000 +13,400	+2,233%	+$11M	0.03%	388
2023 Q3	$494K	Sell	600 -3,000	-83%	-$2.36M	﹤0.01%	1132
2023 Q2	$2.59M	Buy	3,600 +600	+20%	+$463K	0.01%	662
2023 Q1	$2.47M	Buy	+3,000	New	+$2.26M	0.01%	763
2015 Q1	–	Sell	-4,800	Closed	-$1.94M	–	2174
2014 Q4	$1.94M	Sell	4,800 -8,500	-64%	-$3.34M	0.01%	1053
2014 Q3	$4.73M	Buy	13,300 +11,300	+565%	+$3.79M	0.01%	722
2014 Q2	$573K	Buy	+2,000	New	+$593K	﹤0.01%	1704

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Nomura Holdings's REGN Position: Q1 2026 in Review

Nomura Holdings reduced its Regeneron Pharmaceuticals (REGN) stake by 52% in Q1 2026, selling an estimated $15.9M and leaving 19,562 shares worth $15.1M. The position accounts for 0.04% of the portfolio, ranked #323.

Nomura Holdings first reported a position in REGN in Q2 2013 and has held it in 40 quarters since. The position peaked at $31.2M in Q4 2025. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Nomura Holdings held 19,562 shares of Regeneron Pharmaceuticals worth $15.1M as of Q1 2026.
Nomura Holdings sold 20,833 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $15.9M.
Regeneron Pharmaceuticals made up 0.04% of Nomura Holdings's portfolio in Q1 2026, its #323 holding.
Nomura Holdings first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
Nomura Holdings's Regeneron Pharmaceuticals position peaked at $31.2M in Q4 2025.
1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.